RUFINAMIDE
Generic: RUFINAMIDE
Glenmark Pharmaceuticals Inc.Manufacturer
ORALRoute
RUFINAMIDEActive Substance
2016-05-16Original Approval
RUFINAMIDE is FDA application ANDA205075, sponsored by GLENMARK PHARMS LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2023-07-21
Rufinamide Tablets, USP 400 mg, packaged in 120-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 cGMP deviations: Batch was released prior to approval.
Class II2025-03-13
Rufinamide Tablets 200mg, 120-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, MadhyCGMP Deviations
Class II2023-07-21
Rufinamide Tablets, USP 200 mg, packaged in 120-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 cGMP deviations: Batch was released prior to approval.
Top Reported Reactions
1
DRUG INEFFECTIVE
269 reports
2
SEIZURE
252 reports
3
OFF LABEL USE
196 reports
4
SOMNOLENCE
101 reports
5
CONDITION AGGRAVATED
88 reports
6
MULTIPLE-DRUG RESISTANCE
85 reports
7
DRUG INTERACTION
77 reports
8
EPILEPSY
69 reports
9
TREATMENT FAILURE
57 reports
10
HOSPITALISATION
51 reports